Shanghai, China · Founded 2014 · Privately Held (backing)
Operator of a biopharma platform intended to address critical unmet needs in the Asia Pacific region. Nuance Pharma is based in Shanghai, China and was founded in 2014. Its last reported valuation was $623 million in Jul 2025. It has raised $306 million.
Last reported valuation
$623.1M
Oct 2026
Priced at
—
Total raised
$305.8M
Last round
—
Cap table — not yet on record
Nuance Pharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Nuance Pharma with a free account
·Watch Nuance Pharma: the Monday email on marks, rounds and moves
